FIELD: medicine.
SUBSTANCE: prior to begin the therapy, the patient's blood is tested for oestradiol concentration. If the concentration is 18.40 to 29.40 nmol/l, tumour size loss after the neoadjuvant automyelochemotherapy by 67-70% is predicted, that is a partial regress of the tumour, while oestradiol concentration 208.50 to 1541.0 nmol/l enables to predict the tumour size loss by 5-45% that is process stabilisation.
EFFECT: use of the invention allows determining sensitivity of the recurrent breast cancer to the neoadjuvant automyelochemotherapy for an individual correction of treatment policy in patients with said pathology.
1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING DURATION OF RECURRENCE-FREE PERIOD IN RADICALLY TREATED PATIENTS WITH MAMMARY GLAND CANCER | 2009 |
|
RU2413231C2 |
| METHOD OF PROVIDED EFFICIENCY OF NON-ADJUVANT AUTOHEMOCHEMOTHERAPY FOR PATIENTS SUFFERING FROM PAGET-TYPE BREAST CANCER | 2007 |
|
RU2328747C1 |
| METHOD OF PEGET BREAST CANCER TREATMENT | 2006 |
|
RU2325920C1 |
| METHOD OF PREDICTING CHEMORADIOTHERAPY EFFICIENCY IN PATIENTS WITH DISSEMINATED SKIN MELANOMA | 2008 |
|
RU2398238C1 |
| METHOD OF ESTIMATING EFFICIENCY OF NEOADJUVANT AUTOHEMOCHEMOTHERAPY IN PATIENTS SUFFERING FROM CARCINOMA OF CERVIVAL STUMP | 2008 |
|
RU2375063C1 |
| METHOD FOR TREATING MAMMARY GLAND CARCINOMA RELAPSE CASES | 2005 |
|
RU2301088C2 |
| METHOD FOR PREDICTING RECURRENT DISEASE | 2010 |
|
RU2471191C2 |
| METHOD OF ESTIMATING EFFICIENCY OF TREATING PATIENTS WITH HODGKIN'S LYMPHOMA | 2009 |
|
RU2405451C1 |
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS OF AUTOMYELOCHEMORADIATION IN PATIENTS WITH NASOPHARYNGEAL CANCER | 2011 |
|
RU2466405C1 |
| METHOD FOR PRE-OPERATIONAL TREATMENT OF MAMMARY CANCER | 2004 |
|
RU2265440C2 |
